Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Polycystic Ovary Syndrome 1Myelodysplastic-Myeloproliferative Diseases 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Insulin Resistance 1Inflammation 1Hyperandrogenism 1Congenital Abnormalities 1Anovulation 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Metformin 10Clomiphene 10Inositol 3Medroxyprogesterone Acetate 2Letrozole 2Glycoprotein Hormones, alpha Subunit 2Folic Acid 2Chorionic Gonadotropin 2salicylsalicylic acid 1maltodextrin 1Vitamin D 1Sodium Salicylate 1Raloxifene Hydrochloride 1Progestins 1Progesterone 1Nimodipine 1Lactalbumin 1Inulin 1Flutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Anovulation × Sodium Salicylate × Clear all
NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡